Healthy adults
Conditions
Interventions
Sponsors
Central Research Institute, ITO EN, Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1)Males whose age are 20<=years old<40. (2)Subjects who are between 18.5 kg/m2 or more and less than 25.0 kg/m2 in BMI. (3)Subjects who are judged to be suitable for the test by the investigator.
Exclusion criteria
Exclusion criteria: (1)Males whose age are 20<=years old<40. (2)Subjects who are between 18.5 kg/m2 or more and less than 25.0 kg/m2 in BMI. (3)Subjects who are judged to be suitable for the test by the investigator. (1)Subjects who are with treatment at the time of Advance inspection. (2)Subjects who have severe anemia. (3)Subjects whose blood test values are outside of the reference range at the time of Advance inspection. However this is not applicable to the subjects who are deemed to be able to participate in the test by the investigator. (4)Subjects who are with allergy to the study foods or meals during the hospital stay. (5)Subjects who are with current or past medical history of gastrointestinal disease, cardiovascular disease, nephritis and others. Subjects who are with severe mental disorder. (6) Subjects who are not negative for syphilis, HBs antigen, HCV antibody or HIV antigen/antibody test at the time of Advance inspection. (7)Subjects who cannot stop smoking during the hospital stay. (8)Subjects who took the OTC (including the oriental medicines), the Foods with health claims (Foods for specified health uses and others), the health foods, the supplements and others regularly within the past 1 month at the time of Advance inspection. (9)Subjects who have potential to change the lifestyle in the test period. (10) Subjects who donated 200mL of blood within the past 1 month or 400mL of blood within the past 3 months at the time of Advance inspection. (11)Subjects who are attending other studies or attended other studies within the past 3 months. (12)Subjects who are judged to be unsuitable for the test by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics and metabolism of major components of Matcha | — |
Countries
Japan
Contacts
Public ContactMakoto Kobayashi
ITO EN, Ltd Central Research Institute
Outcome results
None listed